|
1
|
Mammas IN, Greenough A, Theodoridou M,
Kramvis A, Rusan M, Melidou A, Korovessi P, Papaioannou G,
Papatheodoropoulou A, Koutsaftiki C, et al: Paediatric Virology and
its interaction between basic science and clinical practice
(Review). Int J Mol Med. 41:1165–1176. 2018.PubMed/NCBI
|
|
2
|
Mammas IN, Theodoridou M, Kramvis A,
Thiagarajan P, Gardner S, Papaioannou G, Melidou A, Koutsaki M,
Kostagianni G, Achtsidis V, et al: Paediatric Virology: A rapidly
increasing educational challenge. Exp Ther Med. 13:364–377. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mammas IN, Greenough A, Theodoridou M,
Kramvis A, Christaki I, Koutsaftiki C, Koutsaki M, Portaliou DM,
Kostagianni G, Panagopoulou P, et al: Current views and advances on
Paediatric Virology: An update for paediatric trainees. Exp Ther
Med. 11:6–14. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mammas IN, Theodoridou M, Thiagarajan P,
Melidou A, Papaioannou G, Korovessi P, et al: A paediatric
influenza update 100 years after the Skyros island Spanish flu
outbreak. Exp Ther Med (In press).
|
|
5
|
zur Hausen H: Papillomaviruses and cancer:
From basic studies to clinical application. Nat Rev Cancer.
2:342–350. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Grün N, Du J, Ährlund-Richter A, Mirzaie
L, Ramqvist T and Dalianis T: Human papillomavirus (HPV) prevalence
in youth at a youth clinic after the initiation of HPV-catch up
vaccination in comparison to previously obtained HPV prevalence in
the same clinic and to that in high school youth in Sweden. Int J
Mol Med. 42:S162018.
|
|
7
|
Ramqvist T, Du J, Lundén M,
Ahrlund-Richter S, Ferreira J, Marions L, Sparén P, Andersson S and
Dalianis T: Pre-vaccination prevalence of human papillomavirus
types in the genital tract of 15–23-year-old women attending a
youth health clinic in Stockholm, Sweden. Scand J Infect Dis.
43:115–121. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Du J, Nordfors C, Ährlund-Richter A,
Sobkowiak M, Romanitan M, Näsman A, Andersson S, Ramqvist T and
Dalianis T: Prevalence of oral human papillomavirus infection among
youth, Sweden. Emerg Infect Dis. 18:1468–1471. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nordfors C, Grün N, Haeggblom L, Tertipis
N, Sivars L, Mattebo M, Larsson M, Häggström-Nordin E, Tydén T,
Ramqvist T, et al: Oral human papillomavirus prevalence in high
school students of one municipality in Sweden. Scand J Infect Dis.
45:878–881. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Grün N, Ährlund-Richter A, Franzén J,
Mirzaie L, Marions L, Ramqvist T and Dalianis T: Oral human
papillomavirus (HPV) prevalence in youth and cervical HPV
prevalence in women attending a youth clinic in Sweden, a follow
up-study 2013–2014 after gradual introduction of public HPV
vaccination. Infect Dis (Lond). 47:57–61. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Grün N, Ährlund-Richter A, Franzén J,
Mirzaie L, Marions L, Ramqvist T and Dalianis T: Follow-up on oral
and cervical human papillomavirus prevalence 2013–2015 in youth at
a youth clinic in Stockholm, Sweden. Infect Dis (Lond). 48:169–170.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mammas IN, Theodoridou M, Sourvinos G and
Spandidos DA: Exploring effective interventions to increase
adolescents' vaccination against human papillomavirus (HPV). Int J
Mol Med. 42:S172018.
|
|
13
|
Mammas IN and Spandidos DA: Paediatric
Virology as a new educational initiative: An interview with
Nobelist Professor of Virology Harald zur Hausen. Exp Ther Med.
14:3329–3331. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zur Hausen H, Mammas IN and Spandidos DA:
HPV vaccination in boys: Determining the clinical relevance of this
strategy. Exp Ther Med. 14:3327–3328. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mammas IN, Theodoridou M, Koutsaftiki C,
Bertsias G, Sourvinos G and Spandidos DA: Vaccination against Human
Papillomavirus in relation to Financial Crisis: The ‘Evaluation and
Education of Greek Female Adolescents on Human Papillomaviruses'
Prevention Strategies’ ELEFTHERIA Study. J Pediatr Adolesc Gynecol.
29:362–366. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Einstein MH, Schiller JT, Viscidi RP,
Strickler HD, Coursaget P, Tan T, Halsey N and Jenkins D:
Clinician's guide to human papillomavirus immunology: Knowns and
unknowns. Lancet Infect Dis. 9:347–356. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fisher H, Trotter CL, Audrey S,
MacDonald-Wallis K and Hickman M: Inequalities in the uptake of
human papillomavirus vaccination: A systematic review and
meta-analysis. Int J Epidemiol. 42:896–908. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kessels SJ, Marshall HS, Watson M,
Braunack-Mayer AJ, Reuzel R and Tooher RL: Factors associated with
HPV vaccine uptake in teenage girls: A systematic review. Vaccine.
30:3546–3556. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mammas IN and Theodoridou M: Financial
crisis and childhood immunization: When parents disagree. Acta
Paediatr. 102:e145–e146. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gottvall M, Stenhammar C and Grandahl M:
Parents' views of including young boys in the Swedish national
school-based HPV vaccination programme: A qualitative study. BMJ
Open. 7:e0142552017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Batista Ferrer H, Trotter CL, Hickman M
and Audrey S: Barriers and facilitators to uptake of the
school-based HPV vaccination programme in an ethnically diverse
group of young women. J Public Health (Oxf). 38:569–577. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Niyibizi J, Zanré N, Mayrand MH and
Trottier H: The association between adverse pregnancy outcomes and
maternal human papillomavirus infection: A systematic review
protocol. Syst Rev. 6:532017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mammas IN, Sourvinos G and Spandidos DA:
Maternal human papillomavirus (HPV) infection and its possible
relationship with neonatal prematurity. Br J Biomed Sci.
67:222–224. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mammas IN and Spandidos DA: Fighting
against human papillomavirus: The 25-year old contribution of the
University of Crete School of Medicine. J BUON. 20:17–21.
2015.PubMed/NCBI
|
|
25
|
Mammas IN, Sourvinos G and Spandidos DA:
HPV infection and neonatal prematurity. Int J Mol Med.
42:S372018.
|
|
26
|
Bonde U, Joergensen JS, Mogensen O and
Lamont RF: The potential role of HPV vaccination in the prevention
of infectious complications of pregnancy. Expert Rev Vaccines.
13:1307–1316. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ambühl LM, Baandrup U, Dybkær K, Blaakær
J, Uldbjerg N and Sørensen S: Human papillomavirus infection as a
possible cause of spontaneous abortion and spontaneous preterm
delivery. Infect Dis Obstet Gynecol. 2016:30860362016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mosbah A, Barakat R, Nabiel Y and Barakat
G: High-risk and low-risk human papilloma virus in association to
spontaneous preterm labor: A case-control study in a tertiary
center, Egypt. J Matern Fetal Neonatal Med. 31:720–725. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zuo Z, Goel S and Carter JE: Association
of cervical cytology and HPV DNA status during pregnancy with
placental abnormalities and preterm birth. Am J Clin Pathol.
136:260–265. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hong JN, Berggren EK, Campbell SL, Smith
JS and Rahangdale L: Abnormal cervical cancer screening in
pregnancy and preterm delivery. Paediatr Perinat Epidemiol.
28:297–301. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hagensee ME, Slavinsky J III, Gaffga CM,
Suros J, Kissinger P and Martin DH: Seroprevalence of human
papillomavirus type 16 in pregnant women. Obstet Gynecol.
94:653–658. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cho G, Min KJ, Hong HR, Kim S, Hong JH,
Lee JK, Oh MJ and Kim H: High-risk human papillomavirus infection
is associated with premature rupture of membranes. BMC Pregnancy
Childbirth. 13:1732013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Subramaniam A, Lees BF, Becker DA, Tang Y,
Khan MJ and Edwards RK: Evaluation of human papillomavirus as a
risk factor for preterm birth or pregnancy-related hypertension.
Obstet Gynecol. 127:233–240. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Huang QT, Zhong M, Gao YF, Huang LP, Huang
Q, Wang W, Wang ZJ and Yu YH: Can HPV vaccine have other health
benefits more than cancer prevention? A systematic review of
association between cervical HPV infection and preterm birth. J
Clin Virol. 61:321–328. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xiong YQ, Mo Y, Luo QM, Huo ST, He WQ and
Chen Q: The risk of human papillomavirus infection for spontaneous
abortion, spontaneous preterm birth, and pregnancy rate of assisted
reproductive technologies: A systematic review and meta-analysis.
Gynecol Obstet Invest. 83:417–427. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lawton B, Howe AS, Turner N, Filoche S,
Slatter T, Devenish C and Hung NA: Association of prior HPV
vaccination with reduced preterm birth: A population based study.
Vaccine. 36:134–140. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Scheller NM, Pasternak B, Mølgaard-Nielsen
D, Svanström H and Hviid A: Quadrivalent HPV vaccination and the
risk of adverse pregnancy outcomes. N Engl J Med. 376:1223–1233.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Doukas SG: Laryngeal HPV infection in
children: A review of management and treatment of Juvenile Onset
Recurrent Respiratory Papillomatosis. Int J Mol Med.
42:S172018.
|
|
39
|
Mammas IN, Sourvinos G and Spandidos DA:
Human papilloma virus (HPV) infection in children and adolescents.
Eur J Pediatr. 168:267–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sinal SH and Woods CR: Human
papillomavirus infections of the genital and respiratory tracts in
young children. Semin Pediatr Infect Dis. 16:306–316. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Donne AJ and Clarke R: Recurrent
respiratory papillomatosis: An uncommon but potentially devastating
effect of human papillomavirus in children. Int J STD AIDS.
21:381–385. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Silverberg MJ, Thorsen P, Lindeberg H,
Grant LA and Shah KV: Condyloma in pregnancy is strongly predictive
of juvenile-onset recurrent respiratory papillomatosis. Obstet
Gynecol. 101:645–652. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ivancic R, Iqbal H, deSilva B, Pan Q and
Matrka L: Current and future management of recurrent respiratory
papillomatosis. Laryngoscope Investig Otolaryngol. 3:22–34. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Derkay CS, Volsky PG, Rosen CA, Pransky
SM, McMurray JS, Chadha NK and Froehlich P: Current use of
intralesional cidofovir for recurrent respiratory papillomatosis.
Laryngoscope. 123:705–712. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gerein V, Rastorguev E, Gerein J, Jecker P
and Pfister H: Use of interferon-alpha in recurrent respiratory
papillomatosis: 20-year follow-up. Ann Otol Rhinol Laryngol.
114:463–471. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Rosen CA and Bryson PC: Indole-3-carbinol
for recurrent respiratory papillomatosis: Long-term results. J
Voice. 18:248–253. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Sidell DR, Nassar M, Cotton RT, Zeitels SM
and de Alarcon A: High-dose sublesional bevacizumab (avastin) for
pediatric recurrent respiratory papillomatosis. Ann Otol Rhinol
Laryngol. 123:214–221. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Limsukon A, Susanto I, Soo Hoo GW,
Dubinett SM and Batra RK: Regression of recurrent respiratory
papillomatosis with celecoxib and erlotinib combination therapy.
Chest. 136:924–926. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Young DL, Moore MM and Halstead LA: The
use of the quadrivalent human papillomavirus vaccine (gardasil) as
adjuvant therapy in the treatment of recurrent respiratory
papilloma. J Voice. 29:223–229. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Bussu F, Sali M, Gallus R, Vellone VG,
Zannoni GF, Autorino R, Dinapoli N, Santangelo R, Martucci R,
Graziani C, et al: HPV infection in squamous cell carcinomas
arising from different mucosal sites of the head and neck region.
Is p16 immunohistochemistry a reliable surrogate marker? Br J
Cancer. 108:1157–1162. 2013.PubMed/NCBI
|
|
51
|
Almadori G, Cadoni G, Cattani P, Posteraro
P, Scarano E, Ottaviani F, Paludetti G and Maurizi M: Detection of
human papillomavirus DNA in laryngeal squamous cell carcinoma by
polymerase chain reaction. Eur J Cancer 32A. 783–788. 1996.
View Article : Google Scholar
|
|
52
|
Almadori G, Galli J, Cadoni G, Bussu F and
Maurizi M: Human papillomavirus infection and cyclin D1 gene
amplification in laryngeal squamous cell carcinoma: Biologic
function and clinical significance. Head Neck. 24:597–604. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Mammas IN, Sourvinos G, Zaravinos A and
Spandidos DA: Vaccination against human papilloma virus (HPV):
Epidemiological evidence of HPV in non-genital cancers. Pathol
Oncol Res. 17:103–119. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Bouvard V, Baan R, Straif K, Grosse Y,
Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C,
Galichet L, et al WHO International Agency for Research on Cancer
Monograph Working Group, : A review of human carcinogens - Part B:
Biological agents. Lancet Oncol. 10:321–322. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Stransky N, Egloff AM, Tward AD, Kostic
AD, Cibulskis K, Sivachenko A, Kryukov GV, Lawrence MS, Sougnez C,
McKenna A, et al: The mutational landscape of head and neck
squamous cell carcinoma. Science. 333:1157–1160. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Zaravinos A, Mammas IN, Sourvinos G and
Spandidos DA: Molecular detection methods of human papillomavirus
(HPV). Int J Biol Markers. 24:215–222. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zaravinos A: An updated overview of
HPV-associated head and neck carcinomas. Oncotarget. 5:3956–3969.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Baruah P, Lee M, Odutoye T, Williamson P,
Hyde N, Kaski JC and Dumitriu IE: Decreased levels of alternative
co-stimulatory receptors OX40 and 4-1BB characterise T cells from
head and neck cancer patients. Immunobiology. 217:669–675. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Hoffmann TK, Dworacki G, Tsukihiro T,
Meidenbauer N, Gooding W, Johnson JT and Whiteside TL: Spontaneous
apoptosis of circulating T lymphocytes in patients with head and
neck cancer and its clinical importance. Clin Cancer Res.
8:2553–2562. 2002.PubMed/NCBI
|
|
60
|
Reichert TE, Scheuer C, Day R, Wagner W
and Whiteside TL: The number of intratumoral dendritic cells and
zeta-chain expression in T cells as prognostic and survival
biomarkers in patients with oral carcinoma. Cancer. 91:2136–2147.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Badoual C, Hans S, Merillon N, Van Ryswick
C, Ravel P, Benhamouda N, Levionnois E, Nizard M, Si-Mohamed A,
Besnier N, et al: PD-1-expressing tumor-infiltrating T cells are a
favorable prognostic biomarker in HPV-associated head and neck
cancer. Cancer Res. 73:128–138. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Kenter GG, Welters MJ, Valentijn AR, Lowik
MJ, Berends-van der Meer DM, Vloon AP, Essahsah F, Fathers LM,
Offringa R, Drijfhout JW, et al: Vaccination against HPV-16
oncoproteins for vulvar intraepithelial neoplasia. N Engl J Med.
361:1838–1847. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Voskens CJ, Sewell D, Hertzano R, DeSanto
J, Rollins S, Lee M, Taylor R, Wolf J, Suntharalingam M, Gastman B,
et al: Induction of MAGE-A3 and HPV-16 immunity by Trojan vaccines
in patients with head and neck carcinoma. Head Neck. 34:1734–1746.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Wallecha A, French C, Petit R, Singh R,
Amin A and Rothman J: Lm-LLO-based immunotherapies and
HPV-associated disease. J Oncol. 2012:5428512012. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Maciag PC, Radulovic S and Rothman J: The
first clinical use of a live-attenuated Listeria monocytogenes
vaccine: A Phase I safety study of Lm-LLO-E7 in patients with
advanced carcinoma of the cervix. Vaccine. 27:3975–3983. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Forastiere AA: Chemotherapy in the
treatment of locally advanced head and neck cancer. J Surg Oncol.
97:701–707. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Leclerc M, Maingon P, Hamoir M, Dalban C,
Calais G, Nuyts S, Serre A and Grégoire V: A dose escalation study
with intensity modulated radiation therapy (IMRT) in T2N0, T2N1,
T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and
hypopharynx using a simultaneous integrated boost (SIB) approach.
Radiother Oncol. 106:333–340. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Fakhry C, Westra WH, Li S, Cmelak A, Ridge
JA, Pinto H, Forastiere A and Gillison ML: Improved survival of
patients with human papillomavirus-positive head and neck squamous
cell carcinoma in a prospective clinical trial. J Natl Cancer Inst.
100:261–269. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Psyrri A, Licitra L, Lacombe D, Schuuring
E, Budach W, Ozsahin M, Knecht R, Vermorken JB and Langendijk JA:
Strategies to promote translational research within the European
Organisation for Research and Treatment of Cancer (EORTC) Head and
Neck Cancer Group: A report from the Translational Research
Subcommittee. Ann Oncol. 21:1952–1960. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Zaravinos A: HPV as an emerging risk
factor in head and neck carcinomas: An additional vaccination
target? Int J Mol Med. 42:S402018.
|
|
71
|
Achtsidis V and Kozanidou E: The
involvement of human papilloma virus (HPV) in eye's disorders in
neonates and children: An update. Int J Mol Med. 42:S172018.
|
|
72
|
Kaliki S, Arepalli S, Shields CL, Klein K,
Sun H, Hysenj E, Lally SE and Shields JA: Conjunctival papilloma:
Features and outcomes based on age at initial examination. JAMA
Ophthalmol. 131:585–593. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Sjö NC, von Buchwald C, Cassonnet P,
Norrild B, Prause JU, Vinding T and Heegaard S: Human
papillomavirus in normal conjunctival tissue and in conjunctival
papilloma: Types and frequencies in a large series. Br J
Ophthalmol. 91:1014–1015. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Minchiotti S, Masucci L, Serapiao Dos
Santos M, Perrella E, Graffeo R, Lambiase A and Bonini S:
Conjunctival papilloma and human papillomavirus: Identification of
HPV types by PCR. Eur J Ophthalmol. 16:473–477. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
D Kalogeropoulos C and M Moschos M:
Advances in diagnosis and treatment of HPV ocular surface
infections. Med Hypothesis Discov Innov Ophthalmol. 4:31–35.
2015.PubMed/NCBI
|
|
76
|
Chalkia AK, Spandidos DA and Detorakis ET:
Viral involvement in the pathogenesis and clinical features of
ophthalmic pterygium (Review). Int J Mol Med. 32:539–543. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Di Girolamo N: Association of human
papilloma virus with pterygia and ocular-surface squamous
neoplasia. Eye (Lond). 26:202–211. 2012. View Article : Google Scholar : PubMed/NCBI
|
